FDA Grants Priority Review to Vertex’s 1st Triple Combo for CF
The U.S. Food and Drug Administration (FDA) has granted priority review to Vertex’s new drug application for its triple combination —...
New Intra-Nasal Imaging to Examine Airways in Cystic Fibrosis Patients
A simple, minimally invasive new tool for observing differences in the nasal airways of cystic fibrosis patients in vivo at a cellular...
Pharmaxis hopeful of FDA approval for cystic fibrosis inhalation medicine Bronchitol by Q1 2020
Pharmaxis Ltd (ASX:PXS) chief executive officer Gary Phillips updates Proactive Investors on the FDA approval timeframe for the company’s...
Gene Editing Tool Corrects CF-causing Mutations in Patient-derived Cells, Study Shows
Using the CRISPR gene editing tool, a team of researchers was able to permanently correct two mutations in the CFTR gene — mutations that...
Powerful weapon discovered to fight antibiotic resistance in Staphylococcus aureus
Staphylococcus aureus bacteria are a major cause of serious infections that often persist despite antibiotic treatment, but scientists at...
Lung damage bacteria sniffed out by dogs in cystic fibrosis research
A new study found the animals can detect ultra-low concentrations of pseudomonas, the commonest cause of lung infection in the disease....
Minimally Invasive Imaging Device Shows Changes in Nasal Airways, May Allow Earlier CF Diagnosis
A minimally invasive imaging device that generates high-resolution images of nasal airways, including the cilia and mucus, allows...
Proteostasis Begins Dosing in Phase 2 Trial of 3 CF Investigational Therapies
The first patient has been dosed in a Phase 2 clinical trial testing Proteostasis Therapeutics‘s combinations of three investigational...
Pregnancy in CF Women With Poor Lung Function Not Linked to Pulmonary Decline, Study Shows
Poorer lung function in pregnant women with cystic fibrosis (CF) is associated with a lower birth weight for offspring, and a higher...
